Recent research at the University of Missouri is examining the impact of diet on cognitive health, particularly through the lens of the ketogenic diet. This high-fat, low-carbohydrate eating plan is being studied for its potential to support brain function and slow cognitive decline, especially in individuals with a genetic predisposition to Alzheimer's disease, specifically those carrying the APOE4 gene.
Led by Professor Ai-Ling Lin and doctoral student Kira Ivanich, the research team investigated how the ketogenic diet affects brain energy levels and gut health in mice with the APOE4 gene. Their findings suggest that female mice on a ketogenic diet exhibited healthier gut bacteria and improved brain energy levels compared to those on a high-carbohydrate diet. However, similar improvements were not observed in male mice, indicating that gender may play a role in dietary benefits.
The study highlights the brain's fuel conversion process. Individuals with the APOE4 gene, particularly females, may struggle to convert glucose from carbohydrates into usable brain energy, potentially leading to cognitive decline. The ketogenic diet offers an alternative fuel source through ketones, which may help preserve brain cell health and reduce the risk of Alzheimer's.
This research is part of a broader movement towards "precision nutrition," which tailors dietary recommendations based on individual factors such as genetics, gut microbiome, and age. Lin emphasizes the importance of early intervention for brain health, advocating for proactive measures before the onset of Alzheimer's symptoms, typically after age 65.
The experiments are facilitated by advanced imaging technologies at the NextGen Precision Health building, allowing for efficient collaboration between preclinical and clinical research. Ivanich's personal connection to Alzheimer's highlights the meaningful potential of their work in enhancing brain health for future generations. The study, titled "Ketogenic diet modulates gut microbiota-brain metabolite axis in a sex-and genotype-specific manner in APOE4 mice," was published in the Journal of Neurochemistry.